Werewolf Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Healthcare Conference

GlobeNewswireNov 20 21:00

Werewolf Therapeutics Analyst Ratings

BenzingaNov 19 19:26 · Ratings

Innovative Cytokine Immunotherapy: Werewolf Therapeutics' Pioneering Approach and Promising Pipeline

TipRanksNov 19 19:25

Werewolf Therapeutics Advances Innovative Cytokine Therapies

TipRanksNov 12 23:11

Leerink Partners Maintains Werewolf Therapeutics(HOWL.US) With Buy Rating, Maintains Target Price $13

Futu NewsNov 12 16:31 · Ratings

Promising Potential of Werewolf Therapeutics' INDUKINE Platform Despite Challenges

TipRanksNov 12 15:45